AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs

AstraZeneca has struck a deal with Donald Trump to provide discounted medicines to the US Medicaid health plan, which is a significant step towards making prescription drugs more affordable for many Americans. This agreement not only aims to lower drug prices but also helps AstraZeneca avoid potential tariffs, showcasing a proactive approach to healthcare and economic challenges. It's a win-win situation that could set a precedent for future negotiations in the pharmaceutical industry.